Amgen Inc.
Combination therapy including an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers

Abstract:

The present invention provides combination therapy that includes an MDM2 inhibitor and one or more additional pharmaceutically active agents, particularly for the treatment of cancers. The invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor and one or more additional pharmaceutically active agents for the treatment of cancers.